Skip to main content
logo
SpringWorks Therapeutics, Inc. (SWTX)
Jul 1, 2025 - SWTX was delisted (reason: acquired by Merck KGaA)
46.99
0.00 (0.00%)
Inactive · Last trade price on Jun 30, 2025

SpringWorks Therapeutics Revenue

SpringWorks Therapeutics had revenue of $49.09M in the quarter ending March 31, 2025, with 133.68% growth. This brings the company's revenue in the last twelve months to $219.67M, up 730.42% year-over-year. In the year 2024, SpringWorks Therapeutics had annual revenue of $191.59M with 3,417.33% growth.

Revenue (ttm)
$219.67M
Revenue Growth
+730.42%
P/S Ratio
15.92
Revenue / Employee
$596,929
Employees
368
Market Cap
3.54B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024191.59M186.14M3,417.33%
Dec 31, 20235.45M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 202035.00M--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SWTX News

More News